DermTech, Inc.

1.53 USD
+0.06 (+4.08%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

DermTech, Inc. stock is up 8.51% since 30 days ago. The next earnings date is Feb 29, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 57.14% of the previous 6 December’s closed higher than November. In the last 2 Unusual Options Trades, there were 2 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
19 Oct 14:02 19 Jan, 2024 5.00 PUT 75 641
30 Oct 14:45 19 Jan, 2024 5.00 PUT 76 641

About DermTech, Inc.

DermTech, Inc. develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. The company sells its products primarily to pathology and oncology practitioners.